UTICORT Drug Patent Profile
Which patents cover Uticort, and what generic alternatives are available?
Uticort is a drug marketed by Parke Davis and is included in four NDAs.
The generic ingredient in UTICORT is betamethasone benzoate. There is one drug master file entry for this compound. Additional details are available on the betamethasone benzoate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for UTICORT?
- What are the global sales for UTICORT?
- What is Average Wholesale Price for UTICORT?
Summary for UTICORT
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 27 |
| Patent Applications: | 1,857 |
| DailyMed Link: | UTICORT at DailyMed |
US Patents and Regulatory Information for UTICORT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Parke Davis | UTICORT | betamethasone benzoate | CREAM;TOPICAL | 016998-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Parke Davis | UTICORT | betamethasone benzoate | OINTMENT;TOPICAL | 018089-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Parke Davis | UTICORT | betamethasone benzoate | GEL;TOPICAL | 017244-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Parke Davis | UTICORT | betamethasone benzoate | LOTION;TOPICAL | 017528-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
